Literature DB >> 30853375

Split luciferase-based assay for simultaneous analyses of the ligand concentration- and time-dependent recruitment of β-arrestin2.

Timo Littmann1, Armin Buschauer2, Günther Bernhardt3.   

Abstract

Functional selectivity of agonists has gained increasing interest in G protein-coupled receptor (GPCR) research, e.g. due to expectations of drugs with reduced adverse effects. Different agonist-dependent GPCR conformations are conceived to selectively activate a balanced or imbalanced intracellular signalling response, involving e.g. different Gα subtypes, Gβγ-subunits and β-arrestins. To discriminate between the different signalling pathways (bias), sensitive techniques are needed that do not interfere with signalling. We applied split luciferase complementation to the GPCR/β-arrestin2 interaction and thoroughly analysed the influence of its implementation on intracellular signalling. This led to an assay enabling the functional characterization of ligands at the hH1R, the hM1,5R and the hNTS1R in live HEK293T cells. As demonstrated at the hM1,5R, the assay was sensitive enough to identify iperoxo as a superagonist. Time-dependent analyses of the recruitment of β-arrestin2 became possible, allowing the identification of class A and class B GPCRs, due to the differential duration of their interaction with β-arrestin2 and their recycling to the cell membrane. The developed β-arrestin2 recruitment assay, which provides concentration- and time-dependent information on the interaction between GPCRs and β-arrestin2 upon stimulation of the receptor, should be broadly applicable and of high value for the analysis of agonist bias.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Bioluminescence; GPCR; Kinetic measurements; Ligand characterization; Split luciferase complementation; β-Arrestin recruitment

Mesh:

Substances:

Year:  2019        PMID: 30853375     DOI: 10.1016/j.ab.2019.02.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors.

Authors:  Xiaoyuan Ma; Rob Leurs; Henry F Vischer
Journal:  Methods Mol Biol       Date:  2021

2.  Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution.

Authors:  Lisa Forster; Steffen Pockes
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

Review 3.  Advances in G protein-coupled receptor high-throughput screening.

Authors:  Emily A Yasi; Nicholas S Kruyer; Pamela Peralta-Yahya
Journal:  Curr Opin Biotechnol       Date:  2020-07-10       Impact factor: 9.740

4.  A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes.

Authors:  Carina Höring; Ulla Seibel; Katharina Tropmann; Lukas Grätz; Denise Mönnich; Sebastian Pitzl; Günther Bernhardt; Steffen Pockes; Andrea Strasser
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

5.  A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D2-Like Receptors.

Authors:  Lisa Forster; Lukas Grätz; Denise Mönnich; Günther Bernhardt; Steffen Pockes
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

6.  BRET-Based Biosensors to Measure Agonist Efficacies in Histamine H1 Receptor-Mediated G Protein Activation, Signaling and Interactions with GRKs and β-Arrestins.

Authors:  Eléonore W E Verweij; Reggie Bosma; Meichun Gao; Jelle van den Bor; Betty Al Araaj; Sabrina M de Munnik; Xiaoyuan Ma; Rob Leurs; Henry F Vischer
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

Review 7.  Protein-fragment complementation assays for large-scale analysis of protein-protein interactions.

Authors:  Ewa Blaszczak; Natalia Lazarewicz; Aswani Sudevan; Robert Wysocki; Gwenaël Rabut
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.